Bone Biologics BBLG Stock
Bone Biologics Price Chart
Bone Biologics BBLG Financial and Trading Overview
| Bone Biologics stock price | 1.17 USD |
| Previous Close | 1.2 USD |
| Open | 1.23 USD |
| Bid | 0.84 USD x 200 |
| Ask | 1.51 USD x 200 |
| Day's Range | 1.18 - 1.23 USD |
| 52 Week Range | 1.05 - 4.13 USD |
| Volume | 11.09K USD |
| Avg. Volume | 59.02K USD |
| Market Cap | 2.12M USD |
| Beta (5Y Monthly) | 0.531 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.2 USD |
BBLG Valuation Measures
| Enterprise Value | -2375728 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.84375 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.45367163 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bone Biologics Stock Price History
| Beta (5Y Monthly) | 0.531 |
| 52-Week Change | -58.041% |
| S&P500 52-Week Change | 19.64% |
| 52 Week High | 4.13 USD |
| 52 Week Low | 1.05 USD |
| 50-Day Moving Average | 1.31 USD |
| 200-Day Moving Average | 1.56 USD |
BBLG Share Statistics
| Avg. Volume (3 month) | 59.02K USD |
| Avg. Daily Volume (10-Days) | 72.03K USD |
| Shares Outstanding | 1.8M |
| Float | 1.79M |
| Short Ratio | 0.57 |
| % Held by Insiders | 0.036% |
| % Held by Institutions | 0.25% |
| Shares Short | 67.28K |
| Short % of Float | 3.75% |
| Short % of Shares Outstanding | 3.75% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.084% |
| Return on Equity (ttm) | -75.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2857887 USD |
| Diluted EPS (ttm) | -1.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.53M USD |
| Total Cash Per Share (mrq) | 2.52 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 16.094 |
| Book Value Per Share (mrq) | 2.601 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2569307 USD |
| Levered Free Cash Flow (ttm) | -1622218 USD |
Profile of Bone Biologics
| Country | United States |
| State | MA |
| City | Burlington |
| Address | 2 Burlington Woods Drive |
| ZIP | 01803 |
| Phone | 781 552 4452 |
| Website | https://www.bonebiologics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Q&A For Bone Biologics Stock
What is a current BBLG stock price?
Bone Biologics BBLG stock price today per share is 1.17 USD.
How to purchase Bone Biologics stock?
You can buy BBLG shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bone Biologics?
The stock symbol or ticker of Bone Biologics is BBLG.
Which industry does the Bone Biologics company belong to?
The Bone Biologics industry is Biotechnology.
How many shares does Bone Biologics have in circulation?
The max supply of Bone Biologics shares is 1.8M.
What is Bone Biologics Price to Earnings Ratio (PE Ratio)?
Bone Biologics PE Ratio is now.
What was Bone Biologics earnings per share over the trailing 12 months (TTM)?
Bone Biologics EPS is -1.13 USD over the trailing 12 months.
Which sector does the Bone Biologics company belong to?
The Bone Biologics sector is Healthcare.
Bone Biologics BBLG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25520.24 USD — |
-1.4
|
6.56B USD — | 25250.63 USD — | 25703.01 USD — | — - | 6.56B USD — |
|
US Tech Health Care
IXHC
US
|
1246.98 USD — |
-0.86
|
— — | 1238.48 USD — | 1258.83 USD — | — - | — — |
- {{ link.label }} {{link}}